Dermatological comorbidity in psoriasis: results from a large-scale cohort of employees

被引:0
作者
N. Zander
I. Schäfer
M. Radtke
A. Jacobi
H. Heigel
M. Augustin
机构
[1] University Medical Center Hamburg-Eppendorf,German Center for Health Services Research in Dermatology (CVderm), Institute for Health Services Research in Dermatology and Nursing (IVDP)
[2] Heigel GmbH,undefined
来源
Archives of Dermatological Research | 2017年 / 309卷
关键词
Psoriasis; Comorbidities; Need for treatment; Epidemiology; Prevalence rates;
D O I
暂无
中图分类号
学科分类号
摘要
The field of dermatological comorbidity in psoriasis is only passively explored with contradictory results. Objective of this study was to further investigate the complex field of psoriasis and associated skin diseases by identifying skin comorbidity patterns in an extensive cohort of employees in Germany. Retrospective analysis of data deriving from occupational skin cancer screenings was conducted. From 2001 to 2014 German employees between 16 and 70 years from different branches underwent single whole-body screenings by trained dermatologists in their companies. All dermatological findings and need for treatment were documented. Point prevalence rates and their 95% confidence intervals were computed. Logistic regression analysis was performed to calculate odds ratios (OR) of single dermatological diseases to occur together with psoriasis controlled for age and sex. Data from 138,930 persons (56.5% male, mean age 43.2) were evaluated. Psoriasis point prevalence was 2.0%. Of those 20.6% had unmet treatment needs of their disease. Onychomycosis was the most frequent dermatological comorbidity with a prevalence of 7.8%. Regression analysis found rosacea (OR = 1.40, 95% CI 1.13–1.72) and telangiectasia (OR = 1.25, 95% CI 1.10–1.41) to be significantly associated with psoriasis. 17.2% of psoriasis patients had at least one further finding requiring treatment. The highest treatment needs were found for onychomycosis (3.4%), tinea pedis (3.1%), and verruca plantaris (1.0%). It can be concluded that persons with psoriasis are at increased risk to suffer from comorbid skin diseases, which should be considered in treatment regimens. Particular attention should be paid to fungal diseases of the feet.
引用
收藏
页码:349 / 356
页数:7
相关论文
共 121 条
[1]  
Alteras I(1986)The incidence of skin manifestations by dermatophytes in patients with psoriasis Mycopathologia 95 37-39
[2]  
Ingberg A(2009)Psöriazisli olgularda tinea pedis ve ayak tirnaği onikomikozu prevalansinin araştirilmasi Mikrobiyol Bul 43 439-447
[3]  
Segal R(2014)Non-segmental vitiligo and psoriasis comorbidity—a case-control study in Italian patients J Eur Acad Dermatol Venereol 28 433-437
[4]  
Altunay ZT(2010)Epidemiology and comorbidity of psoriasis in children Br J Dermatol 162 633-636
[5]  
Ilkit M(2008)Disease severity, quality of life and health care in plaque-type psoriasis: a Multicenter Cross-Sectional Study in Germany Dermatology 216 366-372
[6]  
Denli Y(2010)Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany Acta Derm Venereol 90 147-151
[7]  
Arunachalam M(2011)Systemic treatment with corticosteroids in psoriasis–health care provision far beyond the S3-guidelines J Dtsch Dermatol Ges 9 833-838
[8]  
Dragoni F(2008)Atopic dermatitis N Engl J Med 358 1483-1494
[9]  
Colucci R(2010)Time needed for treatment is the major predictor of quality of life in psoriasis Dermatology 221 154-159
[10]  
Augustin M(2012)Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives Curr Rheumatol Rep 14 343-348